Home   Contact Us   Sitemap



 Financial & IR Update  News Update  Downloads
 
Indoco records 1127 % Q3 growth in PAT
Unaudited Financial Results - Q3 FY10
MDA Notes - Q3 FY10
Concall Transcript - Q3 FY10
Angel Securities Report - Q3 FY10
 
Indoco Remedies Licenses Out Technology to Watson Pharmaceuticals Inc. USA
Indoco Remedies net at Rs 7.73 cr in Q3
Indoco eyes US, Europe markets; will sign four contract research treaties soon
more »